Home › Funds › Rubric Capital Management LP › KNSA

Rubric Capital Management LP position in KNSA

KINIKSA PHARMACEUTICALS INTL · Health Care

Rubric Capital Management LP reported holding 3,999,800 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q2 2026 13F filing — a position valued at US$255.8M, representing 2.36% of its reported portfolio and ranking #9 among its reported holdings. Rubric Capital Management LP has disclosed KNSA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.00M sh
Reported value held$255.79M
Portfolio Weight2.36%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rubric Capital Management LP's KNSA position evolved

Rubric Capital Management LP first disclosed a stake in KNSA in Q3 2023 at 3,077,449 shares (US$53.5M). The position peaked in Q2 2026 at 3,999,800 shares, worth US$255.8M. Across 12 filings, Rubric Capital Management LP increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,999,800 shares valued at US$255.8M — an increase of 249,800 shares quarter over quarter.. Notable position changes include a 29% increase in Q1 2025 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.08M $53.46M New
Q4 2023 2.91M $51.00M Reduce
Q1 2024 2.20M $43.33M Reduce
Q2 2024 2.42M $45.16M Add
Q3 2024 2.42M $60.45M Hold
Q4 2024 2.62M $51.81M Add
Q1 2025 3.38M $75.14M Add
Q2 2025 3.91M $108.18M Add
Q3 2025 4.00M $155.32M Add
Q4 2025 3.33M $137.31M Reduce
Q1 2026 3.75M $180.56M Add
Q2 2026 4.00M $255.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 48 other funds we track also report a position in KNSA — the largest reported positions include BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M), Spruce Street Capital LP (US$58.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has Rubric Capital Management LP held KNSA?

Rubric Capital Management LP has disclosed KNSA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Rubric Capital Management LP's current position in KNSA?

As of Q2 2026, Rubric Capital Management LP holds 4.00M shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $255.79M, representing 2.36% of its reported portfolio and ranking #9.

Has Rubric Capital Management LP been buying or selling KNSA?

In the latest 13F filing (Q2 2026), Rubric Capital Management LP increased its position in KNSA. The position peaked in Q2 2026 at 4.00M shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, Spruce Street Capital LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.